WCN23-1071 GENOME-WIDE ASSOCIATION ANALYSIS OF PROTEIN CODING VARIANTS IN IGA NEPHROPATHY

Ming Li,Yan-Na Wang,Ling Wang,Wee-Yang Meah,Dian-Chun Shi,Khai-Koon Heng,Li Wang,Chiea-Chuen Khor,Jin-Xin Bei,Ching-Yu Cheng,Tin Aung,Yun-Hua Liao,Qin-Kai Chen,Jie-Ruo Gu,Yao-Zhong Kong,Jimmy Lee,Siow-Ann Chong,Mythily Subramaniam,Jia-Nee Foo,Feng-Tao Cai,Geng-Ru Jiang,Gang Xu,Jian-Xin Wan,Meng-Hua Chen,Pei-Ran Yin,Xiu-Qing Dong,Shao-Zhen Feng,Xue-Qing Tang,Zhong,Eng-King Tan,Nan Chen,Hong Zhang,Zhi-Hong Liu,E. Shyong Tai,Jian-Jun Liu,Xue-Qing Yu

DOI: https://doi.org/10.1016/j.ekir.2023.02.562

IF: 6.234

2023-01-01

Kidney International Reports

Abstract:Background Genome-wide association studies have identified nearly 20 susceptibility loci for IgA nephropathy. However, most nonsynonymous coding variants, particularly those occurring rarely or at a low frequency, have not been well investigated. Methods We performed a three-stage exome chip-based association study of coding variants in 8529 patients with IgA nephropathy and 23,224 controls, all of Han Chinese ancestry. Sequencing analysis was conducted to investigate rare coding variants that were not covered by the exome chip. We used molecular dynamic simulation to characterize the effects of mutations of VEGFA on the protein's structure and function. We also explored the relationship between the identified variants and the risk of disease progression. Results We discovered a novel rare nonsynonymous risk variant in VEGFA (odds ratio, 1.97; 95% confidence interval [95% CI], 1.61 to 2.41; P = 3.61x1(0-11)). Further sequencing of VEGFA revealed twice as many carriers of other rare variants in 2148 cases compared with 2732 controls. We also identified a common nonsynonymous risk variant in PKD1L3 (odds ratio, 1.16; 95% CI, 1.11 to 1.21; P 5 1.433x10(-11)), which was associated with lower haptoglobin protein levels. The rare VEGFA mutation could cause a conformational change and increase the binding affinity of VEGFA to its receptors. Furthermore, this variant was associated with the increased risk of kidney disease progression in IgA nephropathy (hazard ratio, 2.99; 95% CI, 1.09 to 8.21; P 5 0.03). Conclusions Our study identified two novel risk variants for IgA nephropathy in VEGFA and PKD1L3 and helps expand our understanding of the genetic basis of IgA nephropathy susceptibility.